U.S. Commercial Services Stock News

MoonLake Immunotherapeutics recently reported that the U.S. FDA, following a Type B meeting, indicated its existing MIRA, VELA-1 and VELA-2 trial data for sonelokimab in hidradenitis suppurativa may be sufficient to support a Biologics License Application, which the company plans to submit in the second half of 2026. An interesting aspect of the FDA feedback is that MoonLake may establish substantial evidence of effectiveness without running additional HS trials, potentially simplifying and...

CNO Financial Group (CNO) shares recently reached an all time high of US$44.06 after third quarter earnings and revenue came in ahead of analyst expectations, followed by an upgrade from Jefferies. See our latest analysis for CNO Financial Group. The latest all time high sits against a solid backdrop, with CNO Financial Group’s 90 day share price return of 10.15% and 1 year total shareholder return of 22.67% pointing to building momentum rather than a short lived spike. If CNO’s move has...

Insider sale and fresh coverage put Peoples Bancorp (PEBO) on investors' radar A recent Buy initiation from DA Davidson and a 1,000 share sale by director Carol A. Schneeberger under a Rule 10b5-1 plan have brought fresh attention to Peoples Bancorp (PEBO). See our latest analysis for Peoples Bancorp. At a share price of US$30.83, Peoples Bancorp has seen mixed short term moves, with a 1 day share price return of 1.44% decline but a 90 day share price return of 5.76%. The 3 year total...

Recent coverage highlighted that First BanCorp’s differentiated product suite, strong loan book performance, and net interest margin of 4.5% have helped underpin earnings power and capital strength in the period leading up to today. An interesting angle is how substantial share buybacks have amplified annual earnings per share growth to very large levels and driven tangible book value per share higher, reinforcing the impact of management’s capital allocation approach. With this context,...

PACS Group (PACS) is back in focus after recent leadership appointments, improved internal controls following an audit, and renewed analyst confidence. Together, these developments are shaping fresh investor interest in the stock. See our latest analysis for PACS Group. Those leadership and governance updates have arrived while the stock has been on a strong run, with a 30 day share price return of 18.63% and a 90 day share price return of 232.82%, contributing to a 1 year total shareholder...

Molson Coors Beverage (TAP) is back in focus as investors weigh ongoing volume declines, pressured margins, and a negative return on capital against upcoming management commentary at February’s CAGNY conference and the 2025 earnings release. See our latest analysis for Molson Coors Beverage. At a share price of US$48.13, Molson Coors has seen a 4.56% 90 day share price return. However, its 1 year total shareholder return of a 4.8% decline suggests fading momentum despite upcoming earnings and...

Goal Investment Management recently announced it has formed a joint venture with Ares Alternative Credit funds to acquire and manage consumer loan portfolios across areas such as education finance, home improvement, solar, and installment lending. This partnership, combined with rising expectations ahead of Ares Management’s upcoming fourth-quarter 2025 earnings release, highlights how the firm is broadening its alternative credit reach and potential fee sources. We’ll now examine how the...

Oshkosh (OSK) is back in the spotlight after multiple CES Picks and Innovation Awards highlighted its AI driven and autonomous safety technologies, including the Collision Avoidance Mitigation System for emergency responders. See our latest analysis for Oshkosh. Those CES awards arrive at a time when momentum in Oshkosh’s shares is strong, with a 13.8% 7 day share price return and a 70.99% 1 year total shareholder return, suggesting growing investor interest in its technology story. If...

If you are wondering whether Victoria's Secret stock still offers value after its recent run, this article will walk through what the current price might be telling you. The shares last closed at US$65.90, with returns of 23.5% over the past week, 20.9% over the last 30 days, 23.5% year to date, 75.4% over 1 year, and 71.7% over 3 years. Recent coverage has focused on Victoria's Secret as a standalone brand and retailer. Investors are paying close attention to how it is repositioning itself...

Earlier this month, DISCO Pharmaceuticals announced an exclusive license agreement granting Amgen global rights to develop and commercialize cancer therapies from DISCO’s cell-surface proteomics platform, with DISCO eligible for up to US$618 million in total deal value plus royalties. This partnership adds another specialized oncology program to Amgen’s pipeline at the same time that investors are closely watching its late-stage obesity and cardiovascular candidates. We’ll now examine how...

Brookfield Infrastructure stock snapshot Brookfield Infrastructure (BIPC) shares have retreated over the past month and past 3 months, with the stock closing at US$43.26. This may prompt investors to reassess the company’s current valuation and fundamentals. See our latest analysis for Brookfield Infrastructure. BIPC’s recent 1 month share price return of a 6.63% decline and 3 month share price return of a 5.07% decline contrast with a 1 year total shareholder return of 18.58%, suggesting...

Market reaction to sector headlines Qfin Holdings (QFIN) came under pressure after shares fell about 4.5%, as U.S. tariff uncertainty and concerns over China’s consumer credit environment weighed on China fintech ADRs and online lending sentiment. See our latest analysis for Qfin Holdings. That tariff driven drop comes on top of a 3.53% one day and 11.66% 30 day share price decline, together with a 35.19% 90 day share price fall and a 49.29% one year total shareholder return loss. This...

Adaptive Biotechnologies recently announced that its subsidiary Digital Biotechnologies, Inc. began a Series A Preferred Stock round targeting up to US$15,000,000 while retaining nearly half ownership, and entered two non-exclusive T-cell receptor discovery and immune data licensing agreements with Pfizer that could yield up to US$890,000,000 in milestone payments. An additional detail for investors is that these Pfizer agreements deepen Adaptive’s role in immune-driven drug development...

Aehr Test Systems (AEHR) is back in focus after securing more than US$5.5 million in new Sonoma burn in system orders tied to AI processors, reinstating second half fiscal 2026 revenue guidance, and introducing a fully automated Sonoma platform. See our latest analysis for Aehr Test Systems. The latest Sonoma orders and reinstated guidance arrive after a mixed few months, with a 1 day share price return of 15.95% and a 7 day share price return of 18.77% lifting sentiment after earlier...

Recently, Clear Secure director Adam Wiener executed his largest recorded open-market sale of 14,000 directly held shares under a pre-arranged Rule 10b5-1 trading plan, while the company also launched a free digital ID product active at more than 250 TSA checkpoints across the United States. This combination of insider activity and the rollout of a free, travel-focused digital identity service highlights Clear Secure’s evolving approach to broadening user access while managing insider share...

In recent days, Telephone and Data Systems drew fresh attention after Citi analyst Michael Rollins reaffirmed a positive view on the company’s prospects, citing ongoing progress in its review of assets such as UScellular and broadband operations. This renewed endorsement comes as investors continue to weigh how management’s exploration of options could influence the long-term shape of the business. We’ll now examine how Citi’s continued confidence in TDS’s strategic review affects the...

Setting the scene for BioLife Solutions (BLFS) BioLife Solutions (BLFS) has been drawing attention after recent share price moves, prompting investors to reassess how its current valuation lines up with its growth in bioproduction products and services for cell and gene therapy. See our latest analysis for BioLife Solutions. The recent move to a share price of $24.86 comes after a mixed period, with a 7 day share price return of 4.06% and a 90 day share price decline of 9.34%. The 1 year...

Cousins Properties recently drew attention after multiple analysts, including BMO Capital, upgraded their ratings, citing improving occupancy trends and a solid balance sheet across its Sun Belt office portfolio. These upgrades emphasized the relative resilience of Cousins’ Class A assets and leasing momentum in markets like Atlanta, Austin, and Charlotte, even as the broader office sector continues to face structural headwinds. We’ll now examine how this wave of analyst upgrades, centered...

In early January 2026, Hayward Holdings reported third-quarter 2025 results that exceeded market expectations on both earnings per share and revenue, while CEO Kevin Holleran exercised options to acquire 52,390 shares at US$1.40 and sold an equal number of shares for about US$837,899. The combination of better-than-expected quarterly performance and insider trading activity offers investors fresh information about Hayward’s operational momentum and leadership’s portfolio decisions. With...

In recent days, Barclays initiated coverage on Badger Meter with an Underweight/Sell rating, citing slowing demand growth for connected water meters as the market matures and pressures in utility spending. This cautious stance contrasts with a generally more positive analyst consensus and comes as Badger Meter maintains strong free cash flow, no debt, and continues investing in smart water technologies and new leadership. We’ll now examine how Barclays’ more cautious view on connected meter...

AutoNation, Inc. has recently expanded its footprint through acquisitions of Toyota in Baltimore, Audi and Mercedes-Benz in Chicago, and Groove Ford and Groove Mazda, while advancing its AutoNation Express digital platform to support online vehicle transactions. At the same time, the board’s approval of an additional US$1.00 billion in share repurchases signals a strong focus on capital returns and balance sheet-driven flexibility. We’ll now examine how this combination of fresh acquisitions...

ESAB recently signed its largest welding and handling equipment contract to date with Titan Wind Energy, supplying highly automated SAW lines, heavy-duty manipulators, and digitally controlled welding systems for Titan’s new monopile manufacturing facility in Cuxhaven. This agreement underscores ESAB’s role as a key technology supplier to offshore wind infrastructure, highlighting how its automation and real-time monitoring capabilities can support demanding 14‑metre‑class monopile...

Belden (BDC) is back in focus after the company appointed Brad Dineley as Executive Vice President, Chief Digital and Operations Officer, a global role reporting directly to the CEO effective January 5, 2026. See our latest analysis for Belden. The appointment of Dineley comes as Belden’s share price has eased in the short term, with a 30-day share price return showing a 6.87% decline and a 90-day share price return showing a 2.60% gain. The 5-year total shareholder return of 173.45% points...

With no single headline driving attention today, Texas Roadhouse (TXRH) has still been drawing interest after a stretch of positive returns, including roughly 7% over the past week and 9% over the past month. See our latest analysis for Texas Roadhouse. That recent 8.9% 1 month share price return sits alongside a 6.9% year to date share price gain, while the 3 year total shareholder return of 90.7% points to strong longer term momentum. If Texas Roadhouse has you looking more closely at...